A science lesson in secure investing
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into…
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into…
Foreseeing a global pandemic is not in any business leader’s job description. But perhaps the most vital skill for today’s…
GlaxoSmithKline (GSK) and Vir Biotechnology have announced an agreement with the UK-based AGILE initiative to conduct Phase Ib/IIa clinical trial of a monoclonal antibody, VIR-7832,…
Eli Lilly and Company has reported that data from Phase II TRAILBLAZER-ALZ study of its investigational antibody, donanemab, showed a significant slowing of decline in…
NeuroRx, Relief Therapeutics and the Quantum Leap Healthcare Collaborative have signed a clinical trial participation agreement to include Zyesami (RLF-100:…
Dr. Reddy’s Laboratories has announced that the Phase II clinical trial of the Russia's Covid-19 vaccine Sputnik V met the…
Canada-based SaNOtize Research and Development has initiated the clinical trials of its nasal spray against Covid-19 at Ashford and St…
Kintor Pharmaceutical has reported encouraging results from the investigator initiated clinical trial of Proxalutamide for treating female Covid-19 patients. In…
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
ORGOVYX™ (relugolix) is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate…
EVERSANA™ and Experic are pleased to announce that they will be partnering to aid life sciences companies in optimising clinical…
When you need customised and scalable filling, packaging and logistics solutions for reservoir and single-dose dry powder inhalation (DPI) devices,…